"High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas

Pancreas

Volumn 43, Issue 8, 2014, Pages 1239-1243

  Aso, Teppei ^a   Ohtsuka, Takao ^a   Matsunaga, Taketo ^a   Kimura, Hideyo ^a   Watanabe, Yusuke ^a   Tamura, Koji ^a   Ideno, Noboru ^a   Osoegawa, Takashi ^a   Takahata, Shunnichi ^a   Shindo, Koji ^a   Ushijima, Yasuhiro ^a   Aishima, Shinichi ^a   Oda, Yoshinao ^a   Ito, Tetsuhide ^a   Mizumoto, Kazuhiro ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Fukuoka guidelines; High risk stigmata; IPMN

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; LOW RISK PATIENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PANCREAS DUCT; PANCREAS RESECTION; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ADENOCARCINOMA, MUCINOUS; CANCER GRADING; CARCINOMA, PANCREATIC DUCTAL; CLASSIFICATION; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; JAPAN; LYMPH NODE DISSECTION; MIDDLE AGED; PANCREATIC NEOPLASMS; PATHOLOGY; SECONDARY; STANDARDS; TUMOR INVASION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; FEMALE; HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84916594956     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000199     Document Type: Article

References (22)

1. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pa nc re at ol og y. 2012; 12:183-197.
2. Tanaka M, Kobayashi K, Mizumoto K., et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005; 40: 669-675.
3. Falconi M, Salvia R, Bassi C., et al. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg. 2001; 88:376-381.
4. Adsay N, Klöppel G, Fukushima N., et al. Intraductal papillary mucinous neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH. et al., eds. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2010:304-313.
5. Tanaka M, Chari S, Adsay V., et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17-32.
6. Schmidt CM, White PB, Waters J.A., et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007; 246:644-651.
7. Ohtsuka T, Kono H, Nagayoshi Y., et al. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012; 151:76-83.
8. Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol. 2011; 8:56-60.
9. Weinberg BM, Spiegel BM, Tomlinson J.S., et al. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010; 138: 531-540.
10. Sadakari Y, Ohuchida K, Nakata K., et al. Invasive carcinoma derived from nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery. 2010; 147:812-817.
11. Tsutsumi K, Ohtsuka T, Oda Y., et al. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology. 2011; 10: 707-712.
12. Aso T, Ohtsuka T, Ideno N., et al. Diagnostic significance of a dilated orifice of the duodenal papilla in intraductal papillary mucinous neoplasm of the pancreas. Gastrointest Endosc. 2012; 76:313-320.
13. Hirota M, Takada T, Kawarada Y., et al. JPN Guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006; 13:33-41.
14. Tamura K, Ohtsuka T, Ideno N., et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014; 259:360-368.
15. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005; 447:794-799.
16. Murakami Y, Uemura K, Hayashidani Y., et al. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg. 2007; 11:338-344.
17. Hirono S, Tani M, Kawai M., et al. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012; 255:517-522.
18. Yamaguchi K, Nakamura M, Shirahane K., et al. Pancreatic juice cytology in IPMN of the pancreas. Pa nc re at ol og y. 2005; 5:416-421.
19. Maire F, Voitot H, Aubert A., et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol. 2008; 103:2871-2877.
20. Schmidt CM, Yip-Schneider MT, Ralstin M.C., et al. PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia. J Gastrointest Surg. 2008; 12:243-249.
21. Maker AV, Lee LS, Raut C.P., et al. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008; 15:3187-3192.
22. Abdeljawad K, Vemulapalli KC, Schmidt C.M., et al. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014; 79: 623-629.